Zobrazeno 1 - 10
of 66
pro vyhledávání: '"Edward E Philpot"'
Publikováno v:
ERJ Open Research, Vol 7, Iss 1 (2021)
This systematic review summarises current evidence to help guide treatment decisions for patients with systemic sclerosis (SSc)-associated interstitial lung disease (ILD). A systematic search of the literature (January 2012 to April 2018), including
Externí odkaz:
https://doaj.org/article/65761329f01e41ca8a67ee2e7008c7c1
Autor:
Ali Ashrafzadeh, Francesco Del Galdo, Toby M. Maher, Edward E Philpot, Cinzia Rotondo, Patricia Carreira, Jörg H W Distler, Peter M. George, Oliver Distler, Rudolf Horváth, Alfredo Guillén-Del-Castillo, Michael Kreuter, Paolo Fraticelli, Suman Paul, Cosimo Bruni, Ivan Foeldvari, Abdul Monem Hamid, Anna-Maria Hoffmann-Vold, Yurdagul Uzunhan, Jacek Olas, Rafic Barake, Manuel Rubio-Rivas, Florentine Moazedi-Fuerst, Ivan Castellví, Andrei Seferian, Paolo Carducci, Michal Tomcik, Ewa Więsik-Szewczyk, Simone Barsotti, Bridget Griffiths, Ulrich A. Walker, Michael Hughes
Publikováno v:
e83
e71
e71
Summary Background Systemic sclerosis-associated interstitial lung disease (ILD) carries a high mortality risk; expert guidance is required to aid early recognition and treatment. We aimed to develop the first expert consensus and define an algorithm
Publikováno v:
ERJ Open Research, Vol 7, Iss 1 (2021)
ERJ Open Res
ERJ Open Res
This systematic review summarises current evidence to help guide treatment decisions for patients with systemic sclerosis (SSc)-associated interstitial lung disease (ILD). A systematic search of the literature (January 2012 to April 2018), including
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::50af0739f1aa1db9cf75ebc50ab09569
Autor:
Ali Ashrafzadeh, Edward E Philpot, Toby M. Maher, Oliver Distler, Anna-Maria Hoffmann-Vold, Michael Kreuter
Publikováno v:
ILD/DPLD of known origin.
Background: Guidelines are needed to aid early recognition and treatment of interstitial lung disease in systemic sclerosis (SSc-ILD). Objective: To develop expert consensus recommendations for the identification and management of SSc-ILD. Methods: E
Publikováno v:
Oral Presentations.
Background Interstitial lung disease in systemic sclerosis (SSc-ILD) occurs frequently and carries a high burden of morbidity and mortality. To date, there are no existing guidelines for screening, diagnosis and management of SSc-ILD that would aid e
Autor:
H. M. Blom, Wei Wu, Bas Rinia, Edward E. Philpot, Cornelis M. van Drunen, Greet Hens, D. Clements, Peter Hellings, Wytske Fokkens, Laurie A. Lee, Ad Jansen
Publikováno v:
American journal of rhinology & allergy, 26(1), 36-44. OceanSide Publications Inc.
Background Fluticasone furoate nasal spray (FFNS) and mometasone furoate nasal spray (MFNS) are well tolerated and more effective than placebo at relieving the symptoms of seasonal and perennial allergic rhinitis. Effects of FFNS on the nasal histolo
Autor:
W. Wu, Neil G Snowise, Tilman Dreykluft, Allan Stillerman, Edward E. Philpot, J. Given, MaryJane Silvey, Amarjit Cheema
Publikováno v:
American Journal of Rhinology & Allergy. 24:444-450
Background Fluticasone furoate nasal spray (FFNS), an intranasal corticosteroid, has been shown to be effective in perennial allergic rhinitis in randomized, double-blind, placebo-controlled studies but has been less extensively studied in perennial
Autor:
Jorge Maspero, Wei Wu, Edward E. Philpot, Richard D Walters, Robert M. Naclerio, Wytske Fokkens
Publikováno v:
Allergy and asthma proceedings, 31(6), 483-492. OceanSide Publications Inc.
Intranasal steroids have been shown to affect ocular symptoms of allergic rhinitis (AR). The results of the published literature, however, are not uniform across all products. This study was designed to evaluate whether the effects of fluticasone fur
Autor:
Barbara A. Prillaman, Edward E. Philpot, Glen E. Journeay, Cindy Garris, Charles P. Andrews, Junghee Lim, Eli O. Meltzer
Publikováno v:
Annals of Allergy, Asthma & Immunology. 104:331-338
Intranasal corticosteroids are first-line treatment for moderate-to-severe seasonal allergic rhinitis (AR).To compare preferences for fluticasone furoate and fluticasone propionate nasal sprays after 1 week of treatment in patients with symptomatic s
Autor:
Robert L. Jacobs, MaryJane Silvey, Edward E. Philpot, Philip Lieberman, Edward Kent, Nicholas Locantore
Publikováno v:
Allergy and Asthma Proceedings. 30:120-127
Vasomotor rhinitis (VMR) is a common but poorly understood disorder of which there are two major subgroups: VMR(w/t), triggered by weather/temperature and VMR(ir), triggered by airborne irritants. No specific biological pathways or specific treatment